Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

Finding out you have HIV can be scary and intimidating news, but so much has changed that now people can lead long and ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...

HIV Treatments: The Basics ... What I Wish I Knew About How Much HIV Treatment Would Progress What I Wish I Knew About the Community I’d Have After My HIV Diagnosis How Is Human Immunodeficiency ...

Code Pharma, a pioneering pharmaceutical company headquartered in the Netherlands, is set to present groundbreaking findings from its clinical trials on GAMMORA, a drug aimed at treating HIV, at two ...

The World Council of Churches has newly published a discussion document: Good News about HIV Treatment, Cure, and Healing: ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

"Madagascar’s HIV epidemic is being fueled by gaps in prevention and glaring inequalities, which urgently need to be ...

The U.S Food and Drug Administration ( FDA) has confirmed the availability of lenacapavir, a two-yearly injectable HIV/ADS treatment as early as the summer 2025, a decision made by FDA after the ...